Last reviewed · How we verify
KVD824 Immediate-Release Capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
KVD824 Immediate-Release Capsule (KVD824 Immediate-Release Capsule) — KalVista Pharmaceuticals, Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| KVD824 Immediate-Release Capsule TARGET | KVD824 Immediate-Release Capsule | KalVista Pharmaceuticals, Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- KVD824 Immediate-Release Capsule CI watch — RSS
- KVD824 Immediate-Release Capsule CI watch — Atom
- KVD824 Immediate-Release Capsule CI watch — JSON
- KVD824 Immediate-Release Capsule alone — RSS
Cite this brief
Drug Landscape (2026). KVD824 Immediate-Release Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/kvd824-immediate-release-capsule. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing